Basilea Pharmaceutica (FRA:PK5) FCF Margin %: 28.49% (As of Dec. 2025)


FRA:PK5 Basilea Pharmaceutica Ltd FRA:PK5
62 GF Score
Price €56.30
GF Value €60.85
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Basilea Pharmaceutica FCF Margin %?

Basilea Pharmaceutica FRA:PK5 +0.90% 62 FCF Margin % is 28.49% as of Dec. 2025. GuruFocus rates FRA:PK5 with a GF Score™ of 62/100 and a GF Value™ of €60.85 (Fairly Valued). The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Basilea Pharmaceutica ranks better than 91.55% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Basilea Pharmaceutica's Free Cash Flow for the six months ended in Dec. 2025 was €39.2 Mil. Basilea Pharmaceutica's Revenue for the six months ended in Dec. 2025 was €137.6 Mil. Therefore, Basilea Pharmaceutica's FCF Margin % for the quarter that ended in Dec. 2025 was 28.49%.

As of today, Basilea Pharmaceutica's current FCF Yield % is 9.21%.

The historical rank and industry rank for Basilea Pharmaceutica's FCF Margin % or its related term are showing as below:

FRA:PK5' s FCF Margin % Range Over the Past 10 Years
Min: -114.32   Med: -9.83   Max: 34.8
Current: 25.5

During the past 13 years, the highest FCF Margin % of Basilea Pharmaceutica was 34.80%. The lowest was -114.32%. And the median was -9.83%.

FRA:PK5's FCF Margin % is ranked better than
91.55% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs FRA:PK5: 25.50

Basilea Pharmaceutica FCF Margin % Related Terms

Basilea Pharmaceutica FCF Margin % Historical Data

* Premium members only.

The historical data trend for Basilea Pharmaceutica's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basilea Pharmaceutica FCF Margin % Chart

Basilea Pharmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.20 2.54 8.38 34.80 25.49

Basilea Pharmaceutica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.36 22.81 41.72 21.78 28.49

FRA:PK5 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Basilea Pharmaceutica's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Basilea Pharmaceutica FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's FCF Margin % falls into.


FRA:PK5
62GF Score
Basilea Pharmaceutica Ltd FRA:PK5
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Basilea Pharmaceutica FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Basilea Pharmaceutica's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=63.472/249.031
=25.49 %

Basilea Pharmaceutica's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=39.208/137.622
=28.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 28.49% mean?
Basilea Pharmaceutica (FRA:PK5) has a FCF Margin % of 28.49% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Basilea Pharmaceutica and its competitors. According to the industry distribution chart, Basilea Pharmaceutica ranks #81 out of 959 companies in the Biotechnology industry, placing it in the top 8.4%.
Is Basilea Pharmaceutica's FCF Margin % too high?
Basilea Pharmaceutica's current FCF Margin % is 28.49%. Based on the distribution chart, Basilea Pharmaceutica ranks #81 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Basilea Pharmaceutica has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Basilea Pharmaceutica's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Basilea Pharmaceutica ranks #81 out of 959 companies for FCF Margin %. This places Basilea Pharmaceutica in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Basilea Pharmaceutica and its competitors. Basilea Pharmaceutica's current FCF Margin % is 28.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basilea Pharmaceutica stock overvalued right now?
Based on GuruFocus' analysis, Basilea Pharmaceutica (FRA:PK5) is currently considered Fairly Valued. The stock's GF Value™ is €60.85, compared to a current price of €56.30 — trading 7.5% below its estimated fair value. The current FCF Margin % is 28.49%. Basilea Pharmaceutica's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Basilea Pharmaceutica (FRA:PK5), the current FCF Margin % is 28.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Basilea Pharmaceutica (FRA:PK5) Overvalued in 2026?

Based on GuruFocus' analysis, Basilea Pharmaceutica stock appears to be undervalued. The current stock price of €56.30 is trading 7.5% below its estimated GF Value™ of €60.85. GuruFocus considers Basilea Pharmaceutica to be Fairly Valued.

Key valuation signals for FRA:PK5:

  • FCF Margin %: 28.49%
  • GF Value™: €60.85 vs. price of €56.30 (7.5% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the FRA:PK5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Basilea Pharmaceutica Business Description

Address Hegenheimermattweg 167b, Allschwil, CHE, 4123
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.
62GF Score

Get the complete analysis for FRA:PK5

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.30
Price
€60.85
GF Value